In the BioHarmony Drug Report Database
Histidine
FreAmine III (histidine) is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target pituitary adenylate cyclase-activating polypeptide type I receptor, solute carrier family 15 member 4, vasoactive intestinal polypeptide receptor 2, secretin receptor, carbonic anhydrase 7, carbonic anhydrase 5A, mitochondrial, carbonic anhydrase 1, sodium-coupled neutral amino acid transporter 5, vasoactive intestinal polypeptide receptor 1, carbonic anhydrase 14, and solute carrier family 15 member 3.
Trade Name
|
FreAmine III |
|---|---|
Common Name
|
histidine |
ChEMBL ID
|
CHEMBL17962 |
Indication
|
|
Drug Class
|
H2-receptor antagonists (cimetidine type) |
Image (chem structure or protein)